Induction of Death Receptors for TRAIL, a Cytotoxic Factor for GVL Effect, by Oncogenic Fusion E2A-HLF Derived from t(17;19)-Positive Acute Lymphoblastic Leukemia.
Xiaochun Zhang(Qingdao University), Kanji Sugita(University of Yamanashi), Hidemitsu Kurosawa(St. Jude Children's Research Hospital), Itaru Kuroda(University of Yamanashi), Takeshi Inukai(University of Yamanashi), Hiroaki Goto(Yokohama City University), Hideo Yagita∥(Juntendo University), Koshi Akahane(University of Yamanashi), A. Thomas Look(Dana-Farber Cancer Institute), Mikiya Endo(Iwate Medical University), Keiko Kagami(University of Yamanashi), Kinuko Hirose(University of Yamanashi), Kumiko Goi(St. Jude Children's Research Hospital), Hiroko Honna(University of Yamanashi), Toshiya Inaba(Hiroshima University)
Cited by 0
Related Papers
Acute lymphoblastic leukaemia
|The Lancet|2008|1.6k
Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia
|Cancer Cell|2002|1.1k
Tumor-infiltrating DCs suppress nucleic acid–mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1
|Nature Immunology|2012|832
<i>FBW7</i> mutations in leukemic cells mediate NOTCH pathway activation and resistance to γ-secretase inhibitors
|The Journal of Experimental Medicine|2007|660
Resolution of inflammation by retrograde chemotaxis of neutrophils in transgenic zebrafish
|Journal of Leukocyte Biology|2006|527